EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic dysregulation contributes to the development of dysferlinopathy

Regula Furrer iD, Sedat Dilbaz iD, Stefan A Steurer, Gesa Santos, Bettina Karrer-Cardel, Danilo Ritz iD, Michael Sinnreich, Christoph Handschin iD

Life Science Alliance · 2025

DOI: 10.26508/lsa.202402991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Regula Furrer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biozentrum, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Dysferlin, Muscular Dystrophies, Limb-Girdle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Swiss Foundation for Research on Muscle Diseases, Jain Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysferlin is a transmembrane protein that plays a prominent role in membrane repair of damaged muscle fibers. Accordingly, mutations in the dysferlin gene cause progressive muscular dystrophies, collectively referred to as dysferlinopathies for which no effective treatment exists. Unexpectedly, experimental approaches that successfully restore membrane repair fail to prevent a dystrophic phenotype, suggesting that additional, hitherto unknown dysferlin-dependent functions contribute to the development of the pathology. Our experiments revealed an altered metabolic phenotype in dysferlin-deficient muscles, characterized by (1) mitochondrial abnormalities and elevated death signaling and (2) increased glucose uptake, reduced glycolytic protein levels, and pronounced glycogen accumulation. Strikingly, elevating mitochondrial volume density and muscle glycogen accelerates disease progression; whereas, improvement of mitochondrial function and recruitment of muscle glycogen with exercise ameliorated functional parameters in a mouse model of dysferlinopathy. Collectively, our results not only shed light on a metabolic function of dysferlin but also imply new therapeutic avenues aimed at promoting mitochondrial function and normalizing muscle glycogen to ameliorate dysferlinopathies, complementing efforts that target membrane repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysferlinMuscular Dystrophies, Limb-GirdleAnimalsMiceGlycogenMuscle, SkeletalDisease Models, AnimalMitochondriaHumansGlucoseMembrane ProteinsGlycolysisMutationMale

Substanzen

DysferlinGlycogenDysf protein, mouseGlucoseMembrane Proteins

Autor:innen und Institutionen

  • Biozentrum, University of Basel, Basel, Switzerland.
  • Department of Biomedicine and Neurology, University and University Hospital Basel, Basel, Switzerland.
  • Biozentrum, University of Basel, Basel, Switzerland christoph.handschin@unibas.ch.

ORCID-Profile: Regula Furrer, Sedat Dilbaz, Danilo Ritz, Christoph Handschin

Förderung

  • Swiss National Science Foundation
  • Swiss Foundation for Research on Muscle Diseases
  • Jain Foundation
  • Gottfried und Julia Bangerter-Rhyner-Stiftung
  • Jubiläumsstiftung der Schweizerischen Lebensversicherungs- und Rentenanstalt für Volksgesundheit und medizinische Forschung
  • Biozentrum PhD Fellowships
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Furrer, R., Dilbaz, S., Steurer, S. A., Santos, G., Karrer-Cardel, B., Ritz, D., Sinnreich, M., & Handschin, C. (2025). Metabolic dysregulation contributes to the development of dysferlinopathy. Life Science Alliance. https://doi.org/10.26508/lsa.202402991

Vancouver

Furrer R, Dilbaz S, Steurer SA, Santos G, Karrer-Cardel B, Ritz D, et al. Metabolic dysregulation contributes to the development of dysferlinopathy. Life Science Alliance. 2025. doi:10.26508/lsa.202402991

BibTeX
@article{Furrer2025,
  author = {Furrer, Regula and Dilbaz, Sedat and Steurer, Stefan A and Santos, Gesa and Karrer-Cardel, Bettina and Ritz, Danilo and Sinnreich, Michael and Handschin, Christoph},
  title = {Metabolic dysregulation contributes to the development of dysferlinopathy},
  journal = {Life Science Alliance},
  year = {2025},
  doi = {10.26508/lsa.202402991}
}
Kostenlos starten →